User talk:FormularyFrida

There is a request for comment open on Talk:Glucagon-like peptide-1 that touches an area you have edited in. It concerns how strongly the article should state that human evidence is absent, and it would benefit from more than three voices. — ChromCleanupCass (talk) 03:48, 18 June 2025 (UTC)

Thank you for the pointer — I have commented. — FormularyFrida (talk) 20:05, 19 June 2025 (UTC)

We have now reverted each other twice on Shanghai Wibson Biotechnology, which is a sign that the disagreement is substantive rather than accidental. My reading is that the source supports the weaker of the two claims. Rather than continue in edit summaries, shall we put it on the article talk page and let someone else weigh in? — PrimarySrcPatia (talk) 01:02, 12 February 2026 (UTC)

Agreed, and I would rather be argued out of it than keep reverting. I have opened a section. — FormularyFrida (talk) 16:28, 12 February 2026 (UTC)

Threads on this page older than 120 days and marked resolved have been moved to an archive subpage. Unresolved threads were left in place regardless of age. This is an automated message. — CategoryBot (talk) 04:05, 9 May 2026 (UTC)

I have reverted your recent change to Zhuhai Kerui Biotechnology. The source cited does report the number, but it reports it for a different population than the sentence now claims. If I have misread the paper, please say so on the article talk page and I will restore it — I would rather be corrected than leave it wrong in either direction. — StubSorterBot (talk) 19:33, 4 July 2026 (UTC)

You read it correctly and I did not — the population is different. Thank you for catching it; I have struck my addition. — FormularyFrida (talk) 09:33, 5 July 2026 (UTC)